APEX HEALTHCARE BERHAD

Malaysia | 7090.KL | Main

By Sustify.world AI model | 2025-05-24
Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, anti-diabetic, anti-hypertensive, neuromuscular agent, analgesic, dermatological, and ophthalmological products in the form of tablets, capsules, oral liquids and suspensions, creams, and sterile eye drops under the Xepa brand name. It also engages in the contract manufacturing of surgical grade orthopedic devices, components, and surgical instruments, as well as orthopedic components that are used in the surgical treatment of musculoskeletal disorders resulting from traumas, diseases, injuries, or deformities. In addition, the company is involved in the retail of pharmaceutical products; rental and management of properties; brand management activities; and provision of accounting and management consultancy services. Further, it commercializes pharmaceuticals, consumer healthcare products, and medical devices under the Zynexis brand name. The company was founded in 1962 and is headquartered in Malacca, Malaysia.

Reference

Report Year: 2023
Source Files: AHEALTH_-_Annual_Report_-_2023.pdf

Sustainability Committee

Sustainability Committee (Unknown pax) 🟢

  • Oversight by RSC 🟢
  • GSMC since 2018 🟢
  • GSTC since 2022 🟢

Reporting

GRI, Bursa Malaysia Guide, Integrated Report 🟢

GHG Accounting

Apex Healthcare Berhad's GHG accounting efforts are at an early stage with a baseline year set at 2023 for data collection, which is a positive starting point 🟢. However, the report lacks specific data on Scope 1, 2, and 3 emissions, boundary definitions, GWP basis, and standards used, limiting transparency ⚠️. There is no mention of third-party verification, as the company acknowledges the absence of an assurance process. While the focus on climate management and resilience is noted, actionable metrics and outcomes are missing. The company should prioritize detailed GHG reporting, adopt recognized standards like the GHG Protocol, and pursue third-party verification to enhance credibility. Addressing these gaps will strengthen stakeholder trust and align with global sustainability expectations.

Emissions

Scope Value Note
Scope1 Not reported ⚠️ Scope 1 emissions data not provided in the report.
Scope2 Not reported ⚠️ Scope 2 emissions data not provided in the report.
Scope3 Not reported ⚠️ Scope 3 emissions data not provided in the report.
Biogenic emissions Not applicable → No biomass or biofuel usage reported.

Other Details

  • Base year: Base Year: 2023 🟢
  • Boundary inventory: Not specified ⚠️
  • Gwp basis: Not specified ⚠️
  • Standard: Not specified ⚠️
  • Third party verification: Not verified ⚠️
  • Carbon intensity: Not reported ⚠️

Efforts

  • No data ⚠️
  • Waste management focus 🟢
  • Solar energy adoption 🌞
  • No data ⚠️

Social Highlights

  • Community health programs 🥗
  • Health talks & screenings 🟢
  • Limited data available ⚠️
  • Limited data available ⚠️
  • Limited data available ⚠️

Governance

  • Salary disclosure: Can't find ⚠️
  • Litigation: Can't find ⚠️

Report Quality

Commendable Foundation in Apex Healthcare Berhad's 2023 Sustainability Statement 🟢. The report demonstrates a structured governance approach with dedicated committees (RSC, GSMC, GSTC) and alignment with GRI and Bursa Malaysia frameworks, reflecting a commitment to transparency. However, the lack of quantifiable data on GHG emissions, waste reduction, and other key metrics is a significant gap ⚠️. While the company sets 2023 as a baseline year, there are no measurable outcomes or specific targets disclosed, and generic statements like 'commitment to environmental stewardship' lack supporting evidence. Forward-looking commitments are mentioned, such as enhancing reporting and setting objectives, which is promising 🟢. To improve, the company should incorporate specific, measurable targets, pursue third-party verification for credibility, and provide detailed performance data. This will elevate the report from a narrative foundation to a robust, actionable document.

Tags:

Looking for ESG Strategy & Improvement?

Disclaimer:

This is AI model generated summary based on certain rules set by Sustify.world perspective. If the reader finds the information is incorrect, they can always approach us by sending email admin@sustify.world.

Need Expert help?
Contact us TODAY for sustainability strategy, reporting, and outsourcing services.

Let's talk

Similar Companies

IHH HEALTHCARE BERHAD | Main | 5225.KL
KPJ HEALTHCARE BERHAD | Main | 5878.KL
more -->

We use cookies to enhance your experience on our website. By clicking "Accept", you agree to our use of cookies. Learn more.